Update in Testosterone Therapy for Men (CME)
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Introduction: Male hypogonadism is a condition characterized by inadequate testicular production of sex steroids and sperms; however, the term is more commonly used to identify testosterone (T) deficiency. When fertility is not desired, T replacement therapy (TRT) is the gold standard. Aim: To review the pathogenesis of male hypogonadism and the available preparations for TRT, along with the main clinical outcomes. Methods: A systematic search of published evidence was performed using Medline (1969 to September 2010). Data from a consecutive series of subjects attending our Andrology Unit were also provided to stress the clinical correlates of low T. Inventories available for detecting hypogonadism (including ANDROTEST) were overviewed. Main Outcome Measures: The most important studies regarding the pathogenesis of male hypogonadism and the preparations for its treatment were reviewed. To review TRT outcomes, only meta-analytic studies were considered. Results: The goals of TRT are to alleviate clinical symptoms and to restore serum T levels to the mid-normal range, without significant side effects or safety concerns. Different T formulations have been approved. TRT is associated with a reduction of fat mass, an increase of lean mass, and a possible positive effect on lipid profile and glycometabolic control. Bone density and depressive symptoms are improved by TRT, while effects on cardiovascular risk and frailty are more controversial. No increase of prostate cancer and prostate-related problems has been reported so far. TRT, alone or in combination with phosphodiesterase type 5 inhibitors, is considered the first-line therapy in hypogonadal subjects with erectile dysfunction. Conclusions: T deficiency is highly prevalent in the aging male and represents a sign of physical and sexual frailty. The significance of low T in elderly men has yet to be completely clarified. Large, prospective intervention trials will help solve this dilemma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Self-citationAdverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1972 · Cited by 939
Self-citationInvestigation, treatment and monitoring of late-onset hypogonadism in males
Wang, C., Nieschlag, E., Swerdloff, R., Behre, H. M., Hellstrom, W. J., Gooren, L. J., Kaufman, J. M., Legros, J.-J., Lunenfeld, B., Morales, A., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0601 · Cited by 867
Calof, O. M., Singh, A. B., Lee, M. L., Kenny, A. M., Urban, R. J., Tenover, J. L., & Bhasin, S. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.11.1451 · Cited by 728
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Validation of a screening questionnaire for androgen deficiency in aging males
Morley, J. E., Charlton, E., Patrick, P., Kaiser, F. E., Cadeau, P., McCready, D., & Perry, H. M. (2000) · Metabolism · doi:10.1053/meta.2000.8625 · Cited by 662
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656
MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-3-200802050-00198 · Cited by 529
Research works printed but not linked: 34
- Petak, 2002, American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update, Endocr Pract, 8, 440, 10.4158/EP.8.6.439 · DOI · Paper page
- Corona, 2010, The role of testosterone in erectile dysfunction, Nat Rev Urol, 7, 46, 10.1038/nrurol.2009.235 · DOI · Paper page
- Morelli, 2007, Which patients with sexual dysfunction are suitable for testosterone replacement therapy?, J Endocrinol Invest, 30, 880, 10.1007/BF03349232 · DOI
- Maggi, 2009, Endocrinology of male sexual function, 61
- Corona, 2009, Recognizing late-onset hypogonadism: A difficult task for sexual health care, J Mens Health Gend, 6, 205
- van den Beld, 2000, Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men, J Clin Endocrinol Metab, 85, 3276
- Gray, 1991, Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study, J Clin Endocrinol Metab, 73, 1016, 10.1210/jcem-73-5-1016 · DOI · Paper page
- Orwoll, 2006, Testosterone and estradiol among older men, J Clin Endocrinol Metab, 91, 1336, 10.1210/jc.2005-1830 · DOI · Paper page
- Mikhail, 2006, Does testosterone have a role in erectile function?, Am J Med, 119, 373, 10.1016/j.amjmed.2005.07.042 · DOI
- Traish, 2009, The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction, J Androl, 30, 10, 10.2164/jandrol.108.005215 · DOI · Paper page
- Heinemann, 2004, Can results of the Aging Males’ Symptoms (AMS) scale predict those of screening scales for androgen deficiency?, Aging Male, 7, 211, 10.1080/13685530400004223 · DOI · Paper page
- Morley, 2006, Comparison of screening questionnaires for the diagnosis of hypogonadism, Maturitas, 53, 424, 10.1016/j.maturitas.2005.07.004 · DOI · Paper page
- Simmer, 1961, Arnold Adolph Berthold (1803–1861) Zur Erinnerung an den hundertsten Todestag des Begrunders der experimentellen, Endokrinologie Dtsch Med Wschr, 86, 2186, 10.1055/s-0028-1113073 · doi:10.1055/s-0028-1113073
- Qoubaitary, 2005, Advances in male hormone substitution therapy, Expert Opin Pharmacother, 6, 1493, 10.1517/14656566.6.9.1493 · DOI
- Seftel, 2007, Testosterone replacement therapy for male hypogonadism: Part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents, Int J Impot Res, 19, 2, 10.1038/sj.ijir.3901366 · DOI
- Edelstein, 2007, The latest options and future agents for treating male hypogonadism, Expert Opin Pharmacother, 8, 2991, 10.1517/14656566.8.17.2991 · DOI
- Pfeil, 2008, Current and future testosterone delivery systems for treatment of the hypogonadal male, Expert Opin Drug Deliv, 5, 471, 10.1517/17425247.5.4.471 · DOI
- Behre, 2004, Pharmacology of testosterone preparations, 405
- Snyder, 1980, Treatment of male hypogonadism with testosterone enanthate, J Clin Endocrinol Metab, 51, 1335, 10.1210/jcem-51-6-1335 · DOI · Paper page
- Plymate, 1994, Hypogonadism, Endocrinol Metab Clin North Am, 23, 749, 10.1016/S0889-8529(18)30065-3 · DOI
- Matsumoto, 1994, Hormonal therapy of male hypogonadism, Endocrinol Metab Clin North Am, 23, 857, 10.1016/S0889-8529(18)30072-0 · DOI
- Jain, 2000, Testosterone supplementation for erectile dysfunction: Results of a meta-analysis, J Urol, 164, 371, 10.1016/S0022-5347(05)67363-6 · DOI · Paper page
- Tsertsvadze, 2009, Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: A systematic review and meta-analysis, Ann Intern Med, 151, 650, 10.7326/0003-4819-151-9-200911030-00150 · DOI · Paper page
- Corona, 2010, Androgen regulation of prostate cancer: Where are we now?, J Endocrinol Invest
- Endogenous Hormones and Prostate Cancer Collaborative Group, 2008, Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies, J Natl Cancer Inst, 100, 170, 10.1093/jnci/djm323 · DOI · Paper page
- Morgentaler, 2009, Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth, Eur Urol, 55, 310, 10.1016/j.eururo.2008.09.024 · DOI · Paper page
- Corona, 2010, The relationship of testosterone to prostate-specific antigen in men with sexual dysfunction, J Sex Med, 7, 284, 10.1111/j.1743-6109.2009.01549.x · DOI · Paper page
- Isidori, 2005, Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: A meta-analysis, Clin Endocrinol (Oxf), 63, 280, 10.1111/j.1365-2265.2005.02339.x · DOI · Paper page
- Corona, 2010, Testosterone, cardiovascular disease and the metabolic sindrome, Best Pract Res Clin Endocrinol Metab
- Jones, 2010, Testosterone deficiency: A risk factor for cardiovascular disease?, Trends Endocrinol Metab, 21, 496, 10.1016/j.tem.2010.03.002 · DOI · Paper page
- Haddad, 2007, Testosterone and cardiovascular risk in men: A systematic review and meta-analysis of randomized placebo-controlled trials, Mayo Clin Proc, 82, 29, 10.1016/S0025-6196(11)60964-6 · DOI · Paper page
- Aversa, 2010, Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle aged men with late-onset hypogonadism and metabolic syndrome: Results from a 24-month, randomized, double-blind, placebo-controlled study, J Sex Med, 7, 3495, 10.1111/j.1743-6109.2010.01931.x · DOI · Paper page
- Iervasi, 2003, Low-T3 syndrome: A strong prognostic predictor of death in patients with heart disease, Circulation, 107, 708, 10.1161/01.CIR.0000048124.64204.3F · DOI · Paper page
- Bartalena, 1998, Role of cytokines in the pathogenesis of the euthyroid sick syndrome, Eur J Endocrinol, 138, 603, 10.1530/eje.0.1380603 · DOI
Cited by
Corona, G., Rastrelli, G., Monami, M., Saad, F., Luconi, M., Lucchese, M., Facchiano, E., Sforza, A., Forti, G., Mannucci, E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0955 · Cited by 414
Self-citationBuvat, J., Maggi, M., Guay, A., & Torres, L. O. (2013) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02783.x · Cited by 283
Self-citationHackett, G., Cole, N., Bhartia, M., Kennedy, D., Raju, J., & Wilkinson, P. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12146 · Cited by 182
Khera, M., Adaikan, G., Buvat, J., Carrier, S., El-Meliegy, A., Hatzimouratidis, K., McCullough, A., Morgentaler, A., Torres, L. O., & Salonia, A. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.10.009 · Cited by 177
Corona, G., Rastrelli, G., & Maggi, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.002 · Cited by 177
Self-citation
Metadata
- Authors
- Corona, G., Rastrelli, G., Forti, G., & Maggi, M.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-01
- Volume
- 8
- Issue
- 3
- Pages
- 639-654
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W2152493522
- Cited by
- 124
- References
- 30
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Update in Testosterone Therapy for Men (CME). https://app.cochat.ai/papers/10.1111/j.1743-6109.2010.02200.x
- The paper
- Corona, G., Rastrelli, G., Forti, G., & Maggi, M. (2011). Update in Testosterone Therapy for Men (CME). The Journal of Sexual Medicine. https://doi.org/10.1111/j.1743-6109.2010.02200.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.